Bispecific digoxigenin-binding antibodies for targeted payload delivery

Bispecific Antibodies for Cancer Immunotherapy

(2010) Dafne Müller et al.   BIODRUGS

Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment

(2010) W. B. BERG et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer

(2010) Ian E. Krop et al.   JOURNAL OF CLINICAL ONCOLOGY

Catumaxomab

(2010) Rolf Linke et al.   mAbs

Radioimmunotherapy of Lymphoma: Bexxar and Zevalin

(2010) Stanley J. Goldsmith   SEMINARS IN NUCLEAR MEDICINE

Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case

(2009) Roberto Ronca et al.   IMMUNOBIOLOGY

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β and IL-1Ra

(2008)   ARTHRITIS AND RHEUMATISM

Short-hairpin-RNA-mediated silencing of fucosyltransferase 8 in Chinese-hamster ovary cells for the production of antibodies with enhanced antibody immune effector function

(2008) Vincent Beuger et al.   BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

The Type 1 Insulin-Like Growth Factor Receptor Pathway

(2008) M. M. Chitnis et al.   CLINICAL CANCER RESEARCH